noom weight loss glp 1 GLP-1 Access and Transparency GLP-1 Microdosing Reshapes Weight Loss

In a study published in JAMA Network Open in January 2025, which included more than 125,000 patients, nearly 65 percent of those taking GLP1s for reasons other than Type 2 diabetes discontinued them within one year

This psychological lag is normal and gradually resolves as the new body becomes the familiar one

Theyre particularly beneficial for people who struggle with food cravings, portion control, or have metabolic issues like prediabetes

Furthermore, in female C57BL/6 mice with induced metabolic syndrome and emphysema, treatment with the GLP-1 receptor agonist has been shown to reduce the area of emphysema, as well as to increase the number of CD31+ endothelial cells, probably through reduced inflammation and positive effects on lipid and glucose metabolism